- Home
- BGLC vs WATT Comparison
BGLC vs WATT Comparison
Compare BGLC & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- WATT
- Stock Information
- Founded
- BGLC 2017
- WATT 2012
- Country
- BGLC Malaysia
- WATT United States
- Employees
- BGLC N/A
- WATT N/A
- Industry
- BGLC Medical Specialities
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- BGLC Health Care
- WATT Technology
- Exchange
- BGLC Nasdaq
- WATT Nasdaq
- Market Cap
- BGLC 7.6M
- WATT 3.9M
- IPO Year
- BGLC N/A
- WATT 2014
- Fundamental
- Price
- BGLC $0.37
- WATT $0.61
- Analyst Decision
- BGLC
- WATT Strong Buy
- Analyst Count
- BGLC 0
- WATT 2
- Target Price
- BGLC N/A
- WATT $2.25
- AVG Volume (30 Days)
- BGLC 117.9K
- WATT 132.1K
- Earning Date
- BGLC 11-20-2024
- WATT 11-07-2024
- Dividend Yield
- BGLC N/A
- WATT N/A
- EPS Growth
- BGLC N/A
- WATT N/A
- EPS
- BGLC N/A
- WATT N/A
- Revenue
- BGLC $9,183,168.00
- WATT $370,184.00
- Revenue This Year
- BGLC N/A
- WATT $95.75
- Revenue Next Year
- BGLC N/A
- WATT $834.07
- P/E Ratio
- BGLC N/A
- WATT N/A
- Revenue Growth
- BGLC N/A
- WATT N/A
- 52 Week Low
- BGLC $0.31
- WATT $0.54
- 52 Week High
- BGLC $3.39
- WATT $2.75
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- WATT 47.76
- Support Level
- BGLC $0.38
- WATT $0.56
- Resistance Level
- BGLC $0.49
- WATT $0.61
- Average True Range (ATR)
- BGLC 0.02
- WATT 0.04
- MACD
- BGLC -0.01
- WATT 0.01
- Stochastic Oscillator
- BGLC 5.94
- WATT 67.60
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.